📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Viral entry at the human-animal interface; dissecting the pan-tropic nature of zoonotic viruses.

Lead Research Organisation: THE PIRBRIGHT INSTITUTE
Department Name: Viral Glycoproteins

Abstract

Anthropogenic shifts in patterns of land use, habitat infringement and climate change increase the probability of viruses such as SARS-CoV-2, the causative agent of Covid-19, spilling over into humans and/or animals. In turn, increased urbanisation and global travel, the absence of herd immunity and poor preparedness can contribute to turn a localised epidemic into a global pandemic. However, not all viruses in nature appear to share the same propensity to spill over; some are restricted to individual hosts while others have a broad host-range and represent a much greater risk to humans and/or animals (livestock, pets and wildlife). Developing a better understanding of the factors that determine the 'zoonotic potential' of viruses is especially prescient as we look to improve pandemic preparedness in a post-Covid-19 landscape.

One of the most important factors to understand in this context is how viral entry (the process whereby the virus attaches to and invades a host cell) correlates with zoonotic potential. In general viruses use specific receptors (proteins or sugars) to enter cells. These can vary between hosts, representing an important point of restriction that directly influences host-range and the potential for spill over. Developing an understanding of this relationship for whole taxonomic groups of viruses (genera or families) will help scientists and stakeholders to assess which viruses represent the greatest risk to humans and animals.

Characterising virus receptor usage and host-range at a broad level is technically challenging. For instance, choosing viruses which accurately represent the overall diversity of their family is prone to bias, favouring established pathogens over those isolated in their natural bat or rodent reservoirs. To address this, we have developed and optimised a pipeline which utilises bioinformatic algorithms to unbiasedly select representative viruses. Within this project we will use this approach to characterise the zoonotic potential of the coronavirus and arenavirus families. All human coronaviruses, as well as many of the coronaviruses which infect our pets and livestock, are thought to have a zoonotic origin (bats or rodents). The same is true for the arenaviruses, with viruses like Lassa continually spilling over from their rodent reservoirs. As proof-of-principle we have already gathered this dataset for the morbillivirus genus, uncovering a number of interesting restrictions which may explain the narrower host range of this smaller group (genus) of viruses.

Our experimental pipeline will proceed as follows: Once we have selected representative viruses, we will use a range of state-of-the-art techniques to quantify their receptor usage and host-range. Subsequently, we will use mutagenesis and protein-binding experiments to dissect the genetic determinants of this zoonotic potential. The assembled scientific research team has a longstanding interest in this area, with broad and overlapping interests in the morbillivirus, coronavirus and arenavirus families. Previously, we have identified amino acid changes in animal morbillivirus attachment proteins which convey tropism to human receptors, solved the structures of arenavirus attachment proteins and more recently examined the likely bat-origin of SARS-CoV-2.

The information we generate in this project will be used to improve our pandemic preparedness, helping us to identify high risk pathogens with broad host-ranges (based on entry). Ultimately this information could be used to design new drugs and vaccines, hopefully preventing future disease in humans and animals.

Technical Summary

In order to forewarn future viral zoonotic spill-overs at the human-animal interface, or animal to animal spill-overs which jeopardise livestock, companion animal or wildlife health, it is essential to develop a broader understanding of the important contributory factors. Viral entry is particularly significant in this context, with efficient receptor usage and host-range being intrinsically linked co-variables. Developing the capacity to define the zoonotic potential of individual pathogens, or ideally groups of pathogens, will provide an evidence-base for risk assessment, improving preparedness in a post-Covid environment. Achieving these goals at a genus or family wide level is complicated by the availability and unbiased selection of representative isolates; however, using a 'greedy' maximum phylogenetic distance algorithm, in combination with gene synthesis and viral pseudotyping, we have developed a pipeline to successfully conduct such screens. Building on preliminary data gathered for the morbilliviruses we propose to expand our analysis to the coronaviruses and arenaviruses, leveraging our existing knowledge of their entry mechanisms to screen the receptor usage patterns of an unbiasedly selected library of viral glycoproteins. Using a diverse range of host receptors from human, livestock, companion animals and wildlife, we will then characterise the host-range of these viruses, mirroring the approach we successfully employed for SARS-CoV-2 (PLOS Biology, 2020). Subsequently, structure and sequence guided mutagenesis will be used to identify key residues, or motifs, within individual virus-host interactions that contribute to broad or narrow host range. Finally, we will compare our functional receptor usage data to in vitro assessment of receptor binding affinity, using this evidence to examine any correlation between host range and attachment. Combined, this research program can shed new light on the factors underpinning zoonotic potential.
 
Description We have characterised how the ability of viruses to enter cells changes across a viral family. There is a great deal of diversity in the viral kingdom so it's difficult to know which viruses are capable of causing disease and which are not. We have looked at two groups of viruses, the alphacoronaviruses and the new world arenaviruses. Results from the first piece of work on the alphas is available here: https://www.biorxiv.org/content/10.1101/2024.11.22.624870v1. In this paper we show differences between viruses - some can use receptors from lots of animals to infect cells, whereas others are more restricted. This helps us risk assess viruses that might cause disease in humans or animals that we spend time with, e.g. livestock, companion animals as well as wildlife.
Exploitation Route This information can be used to generate tailored risk assessments on specific viruses by governmental agencies and public health bodies. It helps us to understand how viruses jump species and whether certain viruses are inherently more capable of this others. This is part of a large body of work to improve pandemic preparedness and prevention.
Sectors Agriculture

Food and Drink

Healthcare

URL https://www.biorxiv.org/content/10.1101/2024.11.22.624870v1
 
Description WHO led effort to prioritize diseases of epidemic and pandemic threat - member of Paramyxovirus expert group
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a guidance/advisory committee
 
Description A human receptor screening resource for host-pathogen interactions
Amount £547,787 (GBP)
Funding ID MR/X019705/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 08/2023 
End 08/2026
 
Title Development of a serological standard for Nipah virus in collaboration with NIBSC 
Description We have helped to test and characterise a serological standard for NIBSC. 
Type Of Material Technology assay or reagent 
Year Produced 2023 
Provided To Others? No  
Impact None to date - the reagent has yet to be released. 
 
Title Library of Arenavirus and alphacoronavirus receptors and attachment proteins 
Description We have developed a wide database of attachment proteins and receptors for two different virus groups to help better understand virus host range. This was developed in collaboration with a bioinformatician to help select a representative database. 
Type Of Material Technology assay or reagent 
Year Produced 2023 
Provided To Others? No  
Impact None to date - project still ongoing. 
 
Description Collaboration with Bernard Agwanda at National Museum of Kenya 
Organisation National Museums of Kenya
Country Kenya 
Sector Public 
PI Contribution Collaborative discussions on bat prevalence across Kenya and potential for virus spillover into human populations, including wet lab data
Collaborator Contribution Collaborative discussions on bat prevalence across Kenya and potential for virus spillover into human populations, including data on bat distribution, historical sampling sites
Impact None yet
Start Year 2024
 
Description Collaboration with Dr. James Nyagwange at KEMRI 
Organisation Kenyan Institute for Medical Research (KEMRI)
Department KEMRI CGMRC Programme
Country Kenya 
Sector Charity/Non Profit 
PI Contribution Discussions regarding serological evidence for infection of Kenya population with coronaviruses. We have provided reagents.
Collaborator Contribution Discussions regarding serological evidence for infection of Kenya population with coronaviruses. They have provided access to samples and assays.
Impact Publication on SARS2 prevalence and neutralisation of variants was published already: 2. Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya. Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, Akech D, Karia B, Ziraba AK, Maina A, Lambisia A, Omuoyo D, Mugo D, Lucinde R, Owuor S, Konyino G, Newman J, Bailey D, Nduati E, Githinji G, Agoti CN, Bejon P, Scott JAG, Agweyu A, Kagucia W, Warimwe GM, Sande C, Ochola-Oyier LI, Nyagwange J. BMC Infect Dis. 2024 Dec 28;24(1):1474. doi: 10.1186/s12879-024-10367-3. https://pubmed.ncbi.nlm.nih.gov/39732637/
Start Year 2024
 
Description Collaboration with Dr. Joe Grove, CVR-Glasgow on viral entry 
Organisation University of Glasgow
Department MRC - University of Glasgow Centre for Virus Research
Country United Kingdom 
Sector Academic/University 
PI Contribution Development of a HCV fusion assay and analysis of mutants
Collaborator Contribution Larger scale analysis of mechanisms of HCV entry
Impact This work has already been published in eLife.
Start Year 2022
 
Description Collaboration with Dr. Tom Peacock on coronavirus in wildlife including bats 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution We have performed experiments on sarbecovirus host range and shared reagents and plasmids
Collaborator Contribution Tom has performed assays looking at sarbecovirus receptor usage and collaborated with bat ecologists
Impact Publication under review
Start Year 2022
 
Description Collaboration with Rachel Ireland at DSTL 
Organisation Defence Science & Technology Laboratory (DSTL)
Country United Kingdom 
Sector Public 
PI Contribution Providing expertise, reagents and advice on coronavirus and arenavirus biology
Collaborator Contribution Providing expertise, reagents and advice on high containment laboratory research
Impact No outcomes as yet.
Start Year 2023
 
Description Collaboration with Stephen Findlay Wilson at UKHSA 
Organisation Public Health England
Department Public Health England Porton Down
Country United Kingdom 
Sector Public 
PI Contribution Collaboration on Nipah virus research helping to establish CL4 animal models for this virus. We have provided vaccines and biological assays and expertise.
Collaborator Contribution Provision of expertise at CL4 with high risk pathogens
Impact Establishment of assays to examine pathogenesis at CL4
Start Year 2023
 
Description Co-chairing a session at Pandemic Science Institute inaugural meeting in Oxford 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Co-chaired a session on vaccines as part of the PSI's first international meeting in 2023
Year(s) Of Engagement Activity 2023
URL https://www.psi.ox.ac.uk/
 
Description Conference presentations at Microbiology Society 2022 meeting 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Talks from our lab at the Microbiology Society general meeting in Belfast in 2022. Talks were on the immune response to Covid vaccines and SARS-CoV-2 and other viruses' host range.
Year(s) Of Engagement Activity 2022
 
Description Conference presentations at Negative Strand Virus meeting 2022 in Braga, Portugal 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Four members of the research group (Drs Bailey, Jobe and Newman as well as Miss Thakur) travelled to Portugal to present our work on SARS-CoV-2 host range, immunity and also RSV inclusion bodies. We had 2 talks and a poster.
Year(s) Of Engagement Activity 2022
 
Description Invited Seminar at Pandemic Sciences Institute Oxford 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Professional Practitioners
Results and Impact Invited seminar about coronavirus spillover, prediction and understanding the generalism of some zoonotic pathogens. There were many questions afterwards and I polled the audience about their views and whether they had changed on the subject before and after the seminar.
Year(s) Of Engagement Activity 2024
 
Description Invited seminar at KEMRI, Kilifi, Kenya (online) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Professional Practitioners
Results and Impact Invited seminar about coronavirus spillover, prediction and understanding the generalism of some zoonotic pathogens. There were many questions afterwards.
Year(s) Of Engagement Activity 2024
 
Description Invited seminar at Roslin Institute 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Professional Practitioners
Results and Impact Invited seminar about coronavirus spillover, prediction and understanding the generalism of some zoonotic pathogens. There were many questions afterwards and I polled the audience about their views and whether they had changed on the subject before and after the seminar.
Year(s) Of Engagement Activity 2025
 
Description Organisation and attendance at UK-International Coronavirus Network conferences in Slovenia and Belfast 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact The UK-ICN runs networking meetings for coronavirus researchers. The Belfast meeting focused on animal coronaviruses and a GAP analyis in this area led by EU based teams at STAR-IDAZ. The Slovenia meeting was the AGM and had a satellite meeting on Big Data with support from CEFAS and Zoetis for both conferences.
Year(s) Of Engagement Activity 2023
URL https://uk-icn.co.uk/
 
Description Talk at JGV roadshow event in Surrey 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Policymakers/politicians
Results and Impact I spoke to 50-100 scientists about our work on viral zoonosis and host range, including work on morbilliviruses, coronaviruses and arenaviruses
Year(s) Of Engagement Activity 2023
 
Description UK International Coronavirus Network AGM Cambridge 2022 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Three members of the team (myself, Dr. Newman and Miss Thakur) attended the AGM of the UK-ICN - which I am a co-director of - to discuss recent data and network with other coronavirus researchers. We presented talks and DB chaired a session.
Year(s) Of Engagement Activity 2022